Back to search

Article

Biomolecular models of EPI-X4 binding to CXCR4 allow the rational optimization of peptides with therapeutic potential

2020-10-24

Abstract excerpt

<h4>ABSTRACT</h4> The Endogenous Peptide Inhibitor of CXCR4 (EPI-X4) is a body-own fragment of albumin and specific antagonist of the CXC-motif-chemokine receptor 4 (CXCR4). CXCR4 signaling is induced by its sole chemokine ligand CXCL12 and is involved in a plethora of functions including cell homing, differentiation, survival and angiogenesis. Consequently, dysregulation of CXCR4 is involved in a variety of diso...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
3154d763-8eba-5b08-8aff-ea68c3888c5d
DOI
10.1101/2020.10.23.352708
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Biomolecular models of EPI-X4 binding to CXCR4 allow the rational optimization of peptides with therapeutic potentialDOI 10.1101/2020.10.23.352708
Select a neighboring publication to make it the new centre.